Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.
African American
CKD staging
CKD-EPI
GFR (Glomerular filtration rate)
allograft function
chronic kidney disease (CKD)
eGFR (estimated glomerular filtration rate)
end-stage renal disease (ESRD)
kidney transplant
laboratory testing
measurement accuracy
race
race and ethnicity
racial disparities
renal function
serum creatinine
serum cystatin C
transplant
Journal
American journal of kidney diseases : the official journal of the National Kidney Foundation
ISSN: 1523-6838
Titre abrégé: Am J Kidney Dis
Pays: United States
ID NLM: 8110075
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
15
11
2021
accepted:
11
03
2022
pubmed:
20
5
2022
medline:
28
9
2022
entrez:
19
5
2022
Statut:
ppublish
Résumé
Race-free estimated glomerular filtration rate (eGFR) equations incorporating creatinine with and without cystatin C were recently developed and recommended for routine use. However, the performance of these equations among kidney transplant recipients (KTRs) remains unknown. Cross-sectional study to validate the 2021 race-free Chronic Kidney Disease (CKD) Epidemiology Collaboration (CKD-EPI) eGFR equation based on creatinine alone (eGFR KTRs in stable condition (N = 415) from Canada and New Zealand with same-day measurements of creatinine, cystatin C, and glomerular filtration rate (GFR) using radiolabeled diethylenetriaminepentaacetic acid. The 2009 CKD-EPI eGFR Bias, precision, accuracy, and correct classification by CKD stage. Bias was defined as the difference between estimated and measured GFR. Precision was represented by the interquartile range. Accuracy was defined as the percentages of participants with eGFRs within 10%/20%/30% (P 87% of patients studied were White, 3% Black, and 10% other races. Mean measured GFR was 53 ± 19 (SD) mL/min/1.73 m Moderate sample size, few patients had a GFR <30 mL/min/1.73 m Among KTRs, the 2021 race-free CKD-EPI eGFR equations perform similarly to the previous CKD-EPI equations that included race correction terms. No significant difference in performance was observed between the 2021 CKD-EPI eGFR
Identifiants
pubmed: 35588905
pii: S0272-6386(22)00643-6
doi: 10.1053/j.ajkd.2022.03.014
pii:
doi:
Substances chimiques
Cystatin C
0
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
462-472.e1Subventions
Organisme : CIHR
Pays : Canada
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.